A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Explore this paper's citation graph
Summary
A surveillance guideline is proposed using TSH-stimulated Tg levels for patients who have undergone total or near-total thyroidectomy and (131)I ablation for DTC and have no clinical evidence of residual tumor with a serum Tg below 1 micro g/liter during THST.
- Type
- review
- Published
- 2003-04-01
- Cited by
- 651
- References
- 56
- Access
- Open access
- OpenAlex
- https://openalex.org/W1966715409
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:25225901
Keywords
Medicine, Thyroglobulin, Thyroid carcinoma, Guideline, Hormone
References
- Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
- Serum thyroglobulin measurement. Utility in clinical practice.
- n/a not/available
- Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996
- Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective.
- Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.
- Manual for Staging of Cancer
- Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.
- Current status and performance goals for serum thyroglobulin assays.
- Serum thyroglobulin concentrations and (131)I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone.
- Resistance of [18F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine
- Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.
- Dosimetrically Determined Doses of Radioiodine for the Treatment of Metastatic Thyroid Carcinoma
- Clinical Comparison of Whole-Body Radioiodine Scan and Serum Thyroglobulin After Stimulation with Recombinant Human Thyrotropin
- Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
- Report of the consensus development conference on the management of differentiated thyroid cancer in the Netherlands
- Management of Low-Risk Well-Differentiated Thyroid Cancer Based Only on Thyroglobulin Measurement After Recombinant Human Thyrotropin
- Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?
- Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
- Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
Cited by
- Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience
- Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer
- Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer.
- Contemporary management of differentiated thyroid carcinoma.
- Thyroglobulin before Ablation and Correlation with Posttreatment Scanning
- Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.
- Intense 18-fluorodeoxyglucose uptake by the thymus on PET scan does not necessarily herald recurrence of thyroid carcinoma
- Differentiated thyroid cancers of follicular cell origin.
- The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients.
- FDG PET/CT in the detection of metastases in a patient with Tg and 131I WBS negative follicular thyroid cancer.
- A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2
- Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin.
- The epidemiology and aetiology of a rising incidence of papillary thyroid carcinoma in Tasmania
- Aplicación del estudio genético a la evaluación el pronóstico del carcinoma diferenciado de tiroides en una población española
- L’uso del TSH umano ricombinante (rhTSH) nel follow-up del carcinoma tiroideo differenziato
- Serum tumor markers. Part I: Clinical utility.
- Recombinant Human Thyrotropin (rhTSH) in the Follow-Up and Treatment of Patients with Thyroid Cancer
- Cancer biomarkers - current perspectives.
- Serum peptide profiling: identifying novel cancer biomarkers for early disease detection.
- Prognostic value of post-thyroidectomy thyroglobulin levels in patients with differentiated thyroid cancer
Related papers
- [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
- Value of the Estimation of Thyroglobulin Levels in the Surveillance of Treated Differentiated Thyroid Carcinoma
- Serum thyroglobulin in the management of patients with thyroid cancer.
- Effect of Antithyroglobulin Antibody on Thyroglobulin About Differentiated Thyroid Cancer Patients
- Long‐term follow‐up using serial serum thyroglobulin determinations in patients with differentiated thyroid carcinoma
- Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
- Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
- The Role of Routine Diagnostic Radioiodine Whole-Body Scintigraphy in Patients with High-Risk Differentiated Thyroid Cancer